Maarja-liisa -. Nairismagi

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia
Published: March 09, 2021

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia
Published: May 21, 2020

Evaluation of the PIK3 pathway in peripheral T-cell lymphoma and NK/T-cell lymphoma.

Evaluation of the PIK3 pathway in peripheral T-cell lymphoma and NK/T-cell lymphoma.

Journal: British journal of haematology
Published: September 02, 2019

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Journal: Blood
Published: September 18, 2018

Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma.

Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma.

Journal: Blood cancer journal
Published: June 26, 2018

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.

Journal: Blood
Published: January 25, 2018

Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.

Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.

Journal: Haematologica
Published: September 09, 2017

Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma.

Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma.

Journal: Leukemia
Published: July 14, 2017

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study.

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study.

Journal: The Lancet. Oncology
Published: March 07, 2016

Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.

Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.

Journal: Nature genetics
Published: August 06, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026